Search Results 711-720 of 8025 for TNF

  1. A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    About this study. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus ...

  2. Evaluating Childhood Cardiovascular Health Outcomes in NEPTUNE and CureGN - Mayo Clinic

    Nephrotic syndrome is a rare kidney condition that can affect children. They may be more likely to develop heart disease, high blood pressure and high ...

  3. Publications

    Publications. Hines AS, Campbell EH, Reinhart JP, Crum OM, Proffer SL, Brewer JD, Gibson LE, Demer AM. Primary cutaneous melanoma of the breast skin: ...

  4. A Study to Evaluate the Effectiveness and Safety of BG00011 in Participants with Idiopathic Pulmonary Fibrosis (SPIRIT) - Mayo Clinic

    The primary purpose of this study is to evaluate the effectiveness of BG00011 compared with placebo in participants with Idiopathic Pulmonary Fibrosis (IPF).

  5. Untitled

    Page 1. Page 2.

  6. Onset of Neuromuscular Blockade (NMB) - Mayo Clinic

    About this study. The primary aim of this study is to compare the time difference from neuromuscular blocking agent (NMBA) administration to neuromuscular ...

  7. Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer - Mayo Clinic

    Giving the drugs in different combinations may kill more breast cancer cells. Giving combination chemotherapy after surgery may kill any tumor cells that remain ...

  8. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  9. INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure - Mayo Clinic

    About this study. INVESTED will test the hypothesis that high dose trivalent influenza vaccine will reduce cardiopulmonary events to a greater extent than ...

  10. 2024 Graduate Student Research Symposium: Recap, Awards, and Highlights - News Archive - Mayo Clinic College of Medicine & Science

    Learn more about the highlights and awards from the 35th annual Student Research Symposium hosted by Mayo Clinic Graduate School of Biomedical Sciences.